Advanced Therapy Logistics
Advanced Therapy Logistics
Branded intro paragraph for all splash pages in here – WIP
Breakthroughs in cell, gene, and radiopharmaceutical therapies are transforming the future of medicine. Marken’s Advanced Therapy Logistics empowers this progress with world-class solutions, safely managing the most sensitive, groundbreaking, and life-changing treatments.
Purpose-Built for Advanced Therapies…
- Specialized ATL Division: Expert project managers trained in cell & gene therapy (CGT), Radiopharma, and OPO (Organ Procurement Organization) workflows.
- Platinum-Certified Teams & Control Towers: 24/7 oversight, real-time intervention, and proactive risk management.
- End-to-End Solutions: Single logistics partner managing every step, from liquid nitrogen (LN2) shipper supply and secure storage to Qualified Person (QP) release and global regulatory support.
- Global Regulatory Expertise: Seamless navigation of customs, trade compliance, and biospecimen standards across every region.
- Unmatched Reliability: 99.9% on-time delivery—because patients can’t wait.
What we move…
Cell & Gene Therapies
- Autologous & Allogeneic: CAR-T, TILs, NK cells, dendritic cell therapies.
- Gene-Modified: Engineered TCRs, CAR-M macrophages, CRISPR/Cas9.
- Nucleic Acid & mRNA: Personalized vaccines, gene editing, ex/in vivo therapies.
Radioligand & Radiopharma
Ultra-sensitive, low-half-life therapies with timed, secure handoffs.
Organ Procurement & Biologics
Critical chain-of-identity/custody, from donor to recipient.
Only Marken delivers the end-to-end capabilities and expertise needed to support your program from clinical to commercial. Our experts are available to discuss your patient-centric service’s needs. Contact us on +1-800-627-5361 (US) or email info@marken.com
Go beyond with us
Our ever-evolving portfolio includes secure, closed loop supply chain services, end-to-end visibility through data-driven tracking solutions and 24/7 cell and gene control tower monitoring oversight. As the leading partner to safeguard these ultra-sensitive, time and temperature-critical treatments, we go beyond cell and gene orchestration to support patients who rely on us to anticipate, innovate and deliver.
Related resources
Scaling Cold Chain Precision Logistics for the Future of Advanced Therapeutics
2 May 2025
Advanced therapies represent a new era in medicine offering potentially curative treatments for previously intractable diseases. However, their complex manufacturing…
Marken’s Precision Logistics Expedites Delivery of Critical Gene Therapies to Japan
17 April 2025
Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss that required continous -80°C…
Precision Logistics: Optimizing the Supply Chain for Advanced Therapies
5 March 2025
Cell and Gene Therapies (CGTs) are revolutionizing medicine by offering long-term remission and even cures for previously untreatable diseases. However,…
Mastering the Advanced Therapy Supply Chain
29 October 2024
The field of Advanced Therapy Medicinal Products (ATMPs) has seen monumental advancements in recent years, offering groundbreaking treatments for a…
Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 2
20 September 2024
Part 2 of our Orchestrating Outcomes for Logistics interview series highlights how building resilience into every link of the supply chain drives precision, progress and patient-centric innovation
Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 1
20 September 2024
To drive supply chain digitalization, it’s essential to leverage data not only to address immediate challenges but to anticipate and prevent disruptions
Marken Delivers Life-Saving Gene Therapy Treatment Over 3,000 Miles From Germany to the UAE in Under 48 Hours
18 September 2024
Marken was tasked with delivering a life-saving gene therapy treatment for a child suffering from Duchenne muscular dystrophy (DMD) in…
Marken seamlessly orchestrates distribution of first commercial CAR-T therapy drug product from USA to Japan
17 October 2023
Marken successfully orchestrated the distribution of the first commercial CAR-T therapy drug product from the USA to a hospital in…
Marken’s 24/7 Cell & Gene Control Tower Provides Agile Solution for Critical Shipments
9 February 2023
Marken’s Cell and Gene Control Tower re-routed six critical shipments of CAR-T drug products from Amsterdam to the UK and…
Operational Excellence Overcomes Obstacles to Deliver Critical Autologous Cell Therapy
9 February 2023
Marken utilized operational excellence to deliver a critical autologous cell therapy. Although there were many challenges, Marken was able to…
Marken Successfully Safeguards the Viability of Pharmaceutical Samples Within 42 Hours
4 January 2023
The distribution of critical cell samples requires an agile strategy with contingency planning and regulatory expertise to ensure seamless delivery…
Happy Holidays from Marken
21 December 2022
At Marken, we are passionate about patients – always finding a way to deliver for our clients – on-time, within…
Delivering What Matters
Experience the capabilities of three UPS companies uniting as one. Together, we are Marken UPS Healthcare Precision Logistics.
Login and quick links